FATROXIMIN, ενδομαστική αλοιφή
FATROXIMIN, ενδομαστική αλοιφή
Authorised
- Rifaximin
Product identification
Medicine name:
FATROXIMIN, ενδομαστική αλοιφή
Active substance:
- Rifaximin
Target species:
-
Cattle (cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Rifaximin0.10gram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary ointment
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (cow)
-
Milkno withdrawal period
-
Meat and offalno withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD06AX11
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 65434/14-09-2012/K-0036502
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: